Literature DB >> 637640

Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients.

J Laszlo, R Jones, H R Silberman, P M Banks.   

Abstract

The major clinical and pathological features and the long-term follow-up of 27 patients with Felty's syndrome who were treated with splenectomy for sever granulocytpenia and for acute, chronic, or recurrent infection were studied. Granulocyte counts rose within days in most patients, although slow responses and transient granulocytopenia did occur; only 12% of the patients had persistent or recurrent granulocytopenia. Infections resolved promptly in 77% of the patients, more slowly in the remainder, and only one patient had new problems of infection after aplenectomy. Splenic enlargement, present in all but one case, was attributable to expansion of the sinusoidal pulp. The most substantial pathological features of immune stimulation included germinal center hyperplasia and prominent clusters of plasma and preplasma cells within sinuses.

Entities:  

Mesh:

Year:  1978        PMID: 637640

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Pneumococcal septic arthritis after splenectomy in Felty's syndrome.

Authors:  M Brzeski; L Smart; D Baird; R Jackson; R Sturrock
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 2.  Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

Authors:  Tal Gazitt; Thomas P Loughran
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Splenectomy for splenomegaly and secondary hypersplenism.

Authors:  W W Coon
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

4.  The Diagnosis Felt(y) Right: A Case Report of Felty Syndrome With Limited Articular Involvement.

Authors:  Victor E Serrano Santiago; Zack Morgan
Journal:  Cureus       Date:  2022-04-29

5.  Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity.

Authors:  H F Pross; J Pater; I Dwosh; A Giles; L A Gallinger; P Rubin; W E Corbett; P Galbraith; M G Baines
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

6.  Cell mediated autoimmune granulocytopenia in a case of Felty's syndrome.

Authors:  S Slavin; M H Liang
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

7.  The non-leukemic T cell large granular lymphocytic leukemia variant with marked splenomegaly and neutropenia in the setting of rheumatoid arthritis - Felty syndrome and hepatosplenic T cell lymphoma mask.

Authors:  Vadim Gorodetskiy; Natalya Probatova; Yulia Sidorova; Natalia Kupryshina; Tatiana Obukhova; Vladimir Vasilyev; Natalya Ryzhikova; Andrey Sudarikov
Journal:  Am J Blood Res       Date:  2021-06-15

Review 8.  Primary and secondary autoimmune neutropenia.

Authors:  Franco Capsoni; Piercarlo Sarzi-Puttini; Alberto Zanella
Journal:  Arthritis Res Ther       Date:  2005-08-31       Impact factor: 5.156

9.  Felty's Syndrome, Insights and Updates.

Authors:  Mohammad Bagher Owlia; Kam Newman; Mojtaba Akhtari
Journal:  Open Rheumatol J       Date:  2014-12-31

10.  Diffuse disseminated candidiasis in a patient with Felty's syndrome: a case report.

Authors:  Shany Ish-Hurwitz; Zamir Dovrish; Evgeny Edelstein; Joelle Bernheim; Jack Bernheim; Ruth Hadari; Howard Amital
Journal:  Rheumatol Int       Date:  2007-06-19       Impact factor: 3.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.